SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factor

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Cell proliferation, migration, and capillary network formation of endothelial cells are the fundamental steps for angiogenesis, which involves the formation of new blood vessels. The purpose of this study is to investigate the effect of a novel aminothiazole SNS-032 on these critical steps for in vitro angiogenesis using a coculture system consisting of human umbilical vein endothelial cells (HUVECs) and human glioblastoma cells (U87MG). SNS-032 is a potent selective inhibitor of cyclin-dependent kinases 2, 7, and 9, and inhibits both transcription and cell cycle. In this study, we examined the proliferation and viability of HUVECs and U87MG cells in the presence of SNS-032 and observed a dose-dependent inhibition of cellular proliferation in both cell lines. SNS-032 inhibited three-dimensional capillary network formations of endothelial cells. In a coculture study, SNS-032 completely prevented U87MG cell-mediated capillary formation of HUVECs. This inhibitor also prevented the migration of HUVECs when cultured alone or cocultured with U87MG cells. In addition, SNS-032 significantly prevented the production of vascular endothelial growth factor (VEGF) in both cell lines, whereas SNS-032 was less effective in preventing capillary network formation and migration of endothelial cells when an active recombinant VEGF was added to the medium. In conclusion, SNS-032 prevents in vitro angiogenesis, and this action is attributable to blocking of VEGF.

Original languageEnglish (US)
Pages (from-to)370-381
Number of pages12
JournalNeoplasia
Volume9
Issue number5
DOIs
StatePublished - May 2007

Fingerprint

Vascular Endothelial Growth Factor A
Human Umbilical Vein Endothelial Cells
Neoplasms
Endothelial Cells
Coculture Techniques
Cyclin-Dependent Kinase 9
Cell Proliferation
Cyclin-Dependent Kinase 2
Cell Line
N-(5-(((5-(1,1-dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide
Glioblastoma
Cell Movement
Blood Vessels
Cell Cycle

Keywords

  • Angiogenesis
  • Capillary formation
  • Endothelial cells
  • Migration
  • VEGF

ASJC Scopus subject areas

  • Cancer Research

Cite this

SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factor. / Ali, N. Aktar; Choy, Hak; Habib, Amyn A.; Saha, Debabrata.

In: Neoplasia, Vol. 9, No. 5, 05.2007, p. 370-381.

Research output: Contribution to journalArticle

@article{cf5190d511dd426ebf935d99b14c6971,
title = "SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factor",
abstract = "Cell proliferation, migration, and capillary network formation of endothelial cells are the fundamental steps for angiogenesis, which involves the formation of new blood vessels. The purpose of this study is to investigate the effect of a novel aminothiazole SNS-032 on these critical steps for in vitro angiogenesis using a coculture system consisting of human umbilical vein endothelial cells (HUVECs) and human glioblastoma cells (U87MG). SNS-032 is a potent selective inhibitor of cyclin-dependent kinases 2, 7, and 9, and inhibits both transcription and cell cycle. In this study, we examined the proliferation and viability of HUVECs and U87MG cells in the presence of SNS-032 and observed a dose-dependent inhibition of cellular proliferation in both cell lines. SNS-032 inhibited three-dimensional capillary network formations of endothelial cells. In a coculture study, SNS-032 completely prevented U87MG cell-mediated capillary formation of HUVECs. This inhibitor also prevented the migration of HUVECs when cultured alone or cocultured with U87MG cells. In addition, SNS-032 significantly prevented the production of vascular endothelial growth factor (VEGF) in both cell lines, whereas SNS-032 was less effective in preventing capillary network formation and migration of endothelial cells when an active recombinant VEGF was added to the medium. In conclusion, SNS-032 prevents in vitro angiogenesis, and this action is attributable to blocking of VEGF.",
keywords = "Angiogenesis, Capillary formation, Endothelial cells, Migration, VEGF",
author = "Ali, {N. Aktar} and Hak Choy and Habib, {Amyn A.} and Debabrata Saha",
year = "2007",
month = "5",
doi = "10.1593/neo.07136",
language = "English (US)",
volume = "9",
pages = "370--381",
journal = "Neoplasia (United States)",
issn = "1522-8002",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factor

AU - Ali, N. Aktar

AU - Choy, Hak

AU - Habib, Amyn A.

AU - Saha, Debabrata

PY - 2007/5

Y1 - 2007/5

N2 - Cell proliferation, migration, and capillary network formation of endothelial cells are the fundamental steps for angiogenesis, which involves the formation of new blood vessels. The purpose of this study is to investigate the effect of a novel aminothiazole SNS-032 on these critical steps for in vitro angiogenesis using a coculture system consisting of human umbilical vein endothelial cells (HUVECs) and human glioblastoma cells (U87MG). SNS-032 is a potent selective inhibitor of cyclin-dependent kinases 2, 7, and 9, and inhibits both transcription and cell cycle. In this study, we examined the proliferation and viability of HUVECs and U87MG cells in the presence of SNS-032 and observed a dose-dependent inhibition of cellular proliferation in both cell lines. SNS-032 inhibited three-dimensional capillary network formations of endothelial cells. In a coculture study, SNS-032 completely prevented U87MG cell-mediated capillary formation of HUVECs. This inhibitor also prevented the migration of HUVECs when cultured alone or cocultured with U87MG cells. In addition, SNS-032 significantly prevented the production of vascular endothelial growth factor (VEGF) in both cell lines, whereas SNS-032 was less effective in preventing capillary network formation and migration of endothelial cells when an active recombinant VEGF was added to the medium. In conclusion, SNS-032 prevents in vitro angiogenesis, and this action is attributable to blocking of VEGF.

AB - Cell proliferation, migration, and capillary network formation of endothelial cells are the fundamental steps for angiogenesis, which involves the formation of new blood vessels. The purpose of this study is to investigate the effect of a novel aminothiazole SNS-032 on these critical steps for in vitro angiogenesis using a coculture system consisting of human umbilical vein endothelial cells (HUVECs) and human glioblastoma cells (U87MG). SNS-032 is a potent selective inhibitor of cyclin-dependent kinases 2, 7, and 9, and inhibits both transcription and cell cycle. In this study, we examined the proliferation and viability of HUVECs and U87MG cells in the presence of SNS-032 and observed a dose-dependent inhibition of cellular proliferation in both cell lines. SNS-032 inhibited three-dimensional capillary network formations of endothelial cells. In a coculture study, SNS-032 completely prevented U87MG cell-mediated capillary formation of HUVECs. This inhibitor also prevented the migration of HUVECs when cultured alone or cocultured with U87MG cells. In addition, SNS-032 significantly prevented the production of vascular endothelial growth factor (VEGF) in both cell lines, whereas SNS-032 was less effective in preventing capillary network formation and migration of endothelial cells when an active recombinant VEGF was added to the medium. In conclusion, SNS-032 prevents in vitro angiogenesis, and this action is attributable to blocking of VEGF.

KW - Angiogenesis

KW - Capillary formation

KW - Endothelial cells

KW - Migration

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=34249082749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249082749&partnerID=8YFLogxK

U2 - 10.1593/neo.07136

DO - 10.1593/neo.07136

M3 - Article

C2 - 17534442

AN - SCOPUS:34249082749

VL - 9

SP - 370

EP - 381

JO - Neoplasia (United States)

JF - Neoplasia (United States)

SN - 1522-8002

IS - 5

ER -